CATALOGO DEI PRODOTTI DELLA RICERCA

FERRARINI, Isacco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.335
NA - Nord America 1.731
AS - Asia 1.422
SA - Sud America 228
AF - Africa 66
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 3
Totale 5.802
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.678
RU - Federazione Russa 1.198
SG - Singapore 599
CN - Cina 361
IT - Italia 228
GB - Regno Unito 208
DE - Germania 202
BR - Brasile 169
HK - Hong Kong 158
VN - Vietnam 131
FI - Finlandia 99
FR - Francia 95
SE - Svezia 89
IE - Irlanda 84
KR - Corea 40
ID - Indonesia 33
NL - Olanda 30
CA - Canada 29
IN - India 28
AR - Argentina 23
ES - Italia 23
PL - Polonia 22
MX - Messico 20
AT - Austria 19
BJ - Benin 19
AU - Australia 16
TR - Turchia 16
ZA - Sudafrica 16
JP - Giappone 13
UA - Ucraina 11
BD - Bangladesh 10
TG - Togo 10
CO - Colombia 7
CL - Cile 6
IQ - Iraq 6
MA - Marocco 6
PT - Portogallo 6
SC - Seychelles 6
BE - Belgio 5
EC - Ecuador 5
PE - Perù 5
PY - Paraguay 5
IR - Iran 4
VE - Venezuela 4
SA - Arabia Saudita 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
BO - Bolivia 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
GE - Georgia 2
IL - Israele 2
JM - Giamaica 2
KE - Kenya 2
LT - Lituania 2
PK - Pakistan 2
PS - Palestinian Territory 2
RO - Romania 2
TH - Thailandia 2
UZ - Uzbekistan 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
CG - Congo 1
DZ - Algeria 1
EG - Egitto 1
FK - Isole Falkland (Malvinas) 1
HN - Honduras 1
HU - Ungheria 1
JO - Giordania 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
MT - Malta 1
MU - Mauritius 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
SK - Slovacchia (Repubblica Slovacca) 1
UY - Uruguay 1
Totale 5.802
Salva come PNG Salva come JPEG
Città #
Dallas 435
Moscow 432
Singapore 287
Ashburn 170
Chandler 165
Hong Kong 158
Southend 133
Munich 121
Beijing 95
Dublin 78
Helsinki 65
Los Angeles 57
Verona 54
Ho Chi Minh City 43
Jacksonville 42
New York 41
The Dalles 36
Buffalo 29
Lawrence 28
Princeton 28
Hanoi 27
London 26
Woodbridge 26
Milan 24
Jakarta 22
Santa Clara 22
Columbus 20
Jinan 20
São Paulo 20
Warsaw 20
Cotonou 19
Wilmington 19
Houston 17
Nanjing 16
Redondo Beach 16
Ann Arbor 15
Brooklyn 15
Redmond 15
Tianjin 15
Orem 14
Seattle 14
Lappeenranta 13
Melbourne 13
Shenyang 13
Sindelfingen 13
Council Bluffs 12
Denver 12
Vienna 12
Zhengzhou 12
Amsterdam 11
Falkenstein 11
Frankfurt am Main 11
Turku 11
Changsha 10
Lomé 10
Nuremberg 10
Phoenix 10
Tokyo 10
Ankara 9
Dong Ket 9
Fairfield 9
Johannesburg 9
Montreal 9
Seoul 9
Stockholm 9
Chennai 8
Hebei 8
San Francisco 8
Toronto 8
Atlanta 7
Bologna 7
Guangzhou 7
Vancouver 7
Vicenza 7
Chicago 6
Hangzhou 6
Mahé 6
Querétaro 6
Redwood City 6
Rio de Janeiro 6
Trento 6
Washington 6
Barcelona 5
Biên Hòa 5
Bogotá 5
Boston 5
Haikou 5
Haiphong 5
Madrid 5
Manchester 5
Mexico City 5
Nanchang 5
Padua 5
Poplar 5
Taizhou 5
Arezzo 4
Boardman 4
Brasília 4
Brussels 4
Cagliari 4
Totale 3.356
Salva come PNG Salva come JPEG
Nome #
Long-term benefit of IGHV mutated patients in a real-life multicenter cohort of FCR-treated chronic lymphocytic leukemia 197
CXCL12 and [N33A]CXCL12 in 5637 and HeLa Cells: Regulating HER1 Phosphorylation via Calmodulin/Calcineurin 194
Erectile Dysfunction after Allogeneic Hematopoietic Stem Cell Transplant: Results from a Single Center Experience 193
Chronic graft versus host disease is associated with erectile dysfunction in allogeneic hematopoietic stem cell transplant patients: a single-center experience 188
Synthetic PGI-2 (Iloprost) treatment in patients with resistant sclerodermic chronic GVHD (cGVHD) after Allogeneic Hematopoietic Stem Cell Transplantation 170
Activation of Protein Tyrosine Phosphatase Receptor Type γ Suppresses Mechanisms of Adhesion and Survival in Chronic Lymphocytic Leukemia Cells 168
CXCR4- and BCR-triggered integrin activation in B-cell chronic lymphocytic leukemia cells depends on JAK2-activated Bruton's tyrosine kinase 166
BID and the α-bisabolol-triggered cell death program: converging on mitochondria and lysosomes 165
B-cell receptor signaling activity identifies patients with mantle cell lymphoma at higher risk of progression 164
A single amino acid substitution in CXCL12 confers functional selectivity at the beta-arrestin level 145
Efficient lysis of B-chronic lymphocytic leukemia cells by the plant-derived sesquiterpene alcohol α-bisabolol, a dual proapoptotic and antiautophagic agent 143
COVID-19 (SARS-CoV-2 infection) in lymphoma patients: A review 141
Efficacy of R-COMP in comparison to R-CHOP in patients with DLBCL: A systematic review and single-arm metanalysis 141
Oncogenic Mutations of MYD88 and CD79B in Diffuse Large B-Cell Lymphoma and Implications for Clinical Practice 139
Clinical Characteristics and Outcome of West Nile Virus Infection in Patients with Lymphoid Neoplasms: An Italian Multicentre Study 137
Case Report: Rapid renal response to venetoclax monotherapy in a CLL patient with secondary membranous glomerulonephritis 129
Classical Hodgkin lymphoma cells may promote an IL-17-enriched microenvironment 129
Decreased apoptotic priming and loss of BCL-2 dependence are functional hallmarks of Richter's syndrome 128
Long-term remissions with Gilteritinib in early relapse after allogeneic stem cell transplantation of FLT3/NPM1 mutated acute myeloid leukemia 121
Immunologic evidence of a strong association between non-Hodgkin lymphoma and simian virus 40 121
Monocyte-to-macrophage switch reversibly impaired by Ibrutinib. 121
CAT rs1001179 Single Nucleotide Polymorphism Identifies an Aggressive Clinical Behavior in Chronic Lymphocytic Leukemia 119
Pembrolizumab as salvage treatment for T-cell/histiocyte-rich and Epstein-Barr virus-positive large B-cell lymphoma 116
IMMUNE THROMBOCYTOPENIA AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: CASE REPORT AND BRIEF OVERVIEW OF TREATMENT STRATEGIES 104
ONC201 and imipridones: Anti-cancer compounds with clinical efficacy. 103
Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study 102
High prevalence of antibodies reacting to mimotopes of Simian virus 40 large T antigen, the oncoprotein, in serum samples of patients affected by non-Hodgkin lymphoma 100
An updated portrait of monocyte-macrophages in classical Hodgkin lymphoma 99
West Nile Virus Encephalitis in Haematological Setting: Report of Two Cases and a Brief Review of the Literature 98
Evans syndrome secondary to chronic lymphocytic leukaemia: presentation, treatment, and outcome 94
Outcomes of younger patients with mantle cell lymphoma experiencing late relapse (>24 months): the LATE-POD study 91
ONC212 IS A NOVEL MITOCAN ACTING SYNERGISTICALLY WITH GLYCOLYSIS INHIBITION IN PANCREATIC CANCER 91
Continuous venetoclax in treatment-naive TP53 disrupted patients with chronic lymphocytic leukemia: A chronic lymphocytic leukemia campus study 89
The mitochondrial anti-apoptotic dependencies of hematologic malignancies: from disease biology to advances in precision medicine 87
Successful rechallenge with azacytidine and venetoclax after sustained treatment-free remission in a relapsed acute myeloid leukemia patient: a case report 87
Extracellular Vesicles based STAT3 delivery as innovative therapeutic approach to restore STAT3 signaling deficiency 85
A brisk peripheral T-cell reaction following rituximab treatment for follicular lymphoma 77
The Evolving Knowledge on T and NK Cells in Classic Hodgkin Lymphoma: Insights into Novel Subsets Populating the Immune Microenvironment 72
Monocyte-to-platelets ratio (MPR) at diagnosis is associated with inferior progression-free survival in patients with mantle cell lymphoma: a multi-center real-life survey 72
ONC212 is a Novel Mitocan Acting Synergistically with Glycolysis Inhibition in Pancreatic Cancer 65
CATALASE BLOCKING INDUCES APOPTOSIS AND POTENTIATES VENETOCLAX-INDUCED CELL DEATH IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS 65
How COVID-19 pandemic changed our attitude to venetoclax-based treatment in chronic lymphocytic leukemia 64
Real-world Outcomes of Relapsed/Refractory Diffuse Large B-cell Lymphoma Treated With Polatuzumab Vedotin-based Therapy 63
Venetoclax based regimens in octogenarian CLL patients: efficacy, safety and comparison to BTKi in a multicenter cohort 62
Two Distinct Clinical Patterns of Ibrutinib-to-Venetoclax Transition in Relapsed Chronic Lymphocytic Leukemia Patients 61
Rituximab and Bendamustine (BR) Compared with Rituximab, Bendamustine, and Cytarabine (R-BAC) in Previously Untreated Elderly Patients with Mantle Cell Lymphoma 57
SARS-CoV-2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID-19 cohort 55
T CELL/HISTIOCYTE-RICH LARGE B-CELL LYMPHOMA: CLINICO-PATHOLOGICAL FEATURES AND RESPONSE TO IMMUNE CHECKPOINT INHIBITORS 55
Targeting CD19 in diffuse large B-cell lymphoma: An expert opinion paper 54
The Importance of Real-World Data in Evaluating the Safety of Biosimilars: A Descriptive Study of Clinical Practice in an Oncohematological Italian Population 49
Salvage treatment after covalent BTKi failure: An unmet need in clinical practice in Waldenstrom macroglobulinemia 49
First-line treatment of Waldenström's macroglobulinemia in Italy: A multicenter real-life study on 547 patients to evaluate the long-term efficacy and tolerability of different chemoimmunotherapy strategies 45
B-CELL RECEPTOR SIGNALING ACTIVITY IDENTIFIES PATIENTS WITH MANTLE CELL LYMPHOMA AT HIGHER RISK OF PROGRESSION 44
ACTIVATION OF BCR SIGNALING REWIRES THE RESPONSE OF BCR-ASSOCIATED KINASES TO IBRUTINIB IN MANTLE CELL LYMPHOMA CELLS 43
CAT RS1001179 SINGLE NUCLEOTIDE POLYMORPHISM IDENTIFIES AN AGGRESSIVE CLINICAL BEHAVIOR IN CHRONIC LYMPHOCYTIC LEUKEMIA 39
BCR signaling activity stratifies patents with MCL with divergent clinical outcome 37
THE PROGNOSTIC SIGNIFICANCE OF MYC AND BCL2 PROTEIN DOUBLE EXPRESSION IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA, NOS, IN THE ABSENCE OF MYC REARRANGEMENT 34
Outcomes of younger patients with mantle‐cell lymphoma experiencing late relapse (>24 months): the LATE‐POD study 32
PROGNOSTIC AND PREDICTIVE SIGNIFICANCE OF THE B-CELL RECEPTOR SIGNALING IN MANTLE CELL LYMPHOMA 30
Totale 5.889
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.946
article - articoli 18.744
book - libri 0
conference - conferenze 638
curatela - curatele 0
other - altro 564
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.892
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202182 0 0 0 0 0 30 0 6 8 5 14 19
2021/2022219 12 50 2 10 35 4 7 12 4 14 12 57
2022/2023500 30 67 37 92 38 112 11 36 57 6 7 7
2023/2024327 11 30 49 34 25 41 20 26 9 20 49 13
2024/20251.268 46 49 72 180 55 84 84 86 184 83 124 221
2025/20263.067 216 393 290 632 1.302 234 0 0 0 0 0 0
Totale 5.889